{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:16:40Z","timestamp":1762543000994,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672644"],"award-info":[{"award-number":["81672644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12957-019-1568-x","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T13:05:29Z","timestamp":1548939929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance"],"prefix":"10.1186","volume":"17","author":[{"given":"Cheng","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C Vecchia La","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136:2187\u201395.","journal-title":"Int J Cancer"},{"key":"1568_CR2","first-page":"862","volume":"39","author":"L Yang","year":"2017","unstructured":"Yang L, Zheng RS, Wang N, Zeng HM, Yuan YN, Zhang SW, Li HC, Liu S, Chen WQ, He J. Analysis of incidence and mortality of thyroid cancer in China, 2013. Zhonghua Zhong Liu Za Zhi. 2017;39:862\u20137.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijsu.2017.12.035","volume":"50","author":"KR Joseph","year":"2018","unstructured":"Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;50:121\u20135.","journal-title":"Int J Surg"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13:184\u201399.","journal-title":"Nat Rev Cancer"},{"key":"1568_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.prp.2017.09.001","volume":"214","author":"D Chen","year":"2017","unstructured":"Chen D, Qi W, Zhang P, Zhang Y, Liu Y, Guan H, Wang L. Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma. Pathol Res Pract. 2017;214:303\u20137.","journal-title":"Pathol Res Pract"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/cancers10040093","volume":"10","author":"IGDLF Alonso","year":"2018","unstructured":"Alonso IGDLF, Liang H, Turner SD, Lagger S, Merkel O, Kenner L. The role of activator protein-1 (AP-1) family members in CD30-positive lymphomas. Cancers. 2018;10:93.","journal-title":"Cancers"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12967-016-0833-9","volume":"14","author":"JK Li","year":"2016","unstructured":"Li JK, Nie L, Zhao YP, Zhang YQ, Wang X, Wang SS, Liu Y, Zhao H, Cheng L. IL-17 mediates inflammatory reactions via p38\/c-Fos and JNK\/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells. J Transl Med. 2016;14:77.","journal-title":"J Transl Med"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1021\/jm5004733","volume":"57","author":"N Ye","year":"2014","unstructured":"Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem. 2014;57:6930\u201348.","journal-title":"J Med Chem"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.phrs.2017.09.014","volume":"128","author":"D Tewari","year":"2018","unstructured":"Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, Vacca RA, Sethi G, Bishayee A. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2018;128:366\u201375.","journal-title":"Pharmacol Res"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.amjms.2017.01.019","volume":"353","author":"S Trop-Steinberg","year":"2017","unstructured":"Trop-Steinberg S, Azar Y. AP-1 expression and its clinical relevance in immune disorders and cancer. Am J Med Sci. 2017;353:474\u201383.","journal-title":"Am J Med Sci"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1159\/000481871","volume":"43","author":"J Ma","year":"2017","unstructured":"Ma J, Xuan SH, Li Y, Zhang ZP, Li XH. Role of the TGFbeta\/PDCD4\/AP-1 signaling pathway in nasopharyngeal carcinoma and its relationship to prognosis. Cell Physiol Biochem. 2017;43:1392\u2013401.","journal-title":"Cell Physiol Biochem"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3892\/ol.2017.6638","volume":"14","author":"JM Kim","year":"2017","unstructured":"Kim JM, Noh EM, Song HK, Lee M, Lee SH, Park SH, Ahn CK, Lee GS, Byun EB, Jang BS, et al. Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK\/AP-1 signaling pathway in human breast cancer MCF-7 cells. Oncol Lett. 2017;14:3594\u2013600.","journal-title":"Oncol Lett"},{"issue":"5","key":"1568_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3727\/096504017X14982585511252","volume":"26","author":"S Liu","year":"2017","unstructured":"Liu S, Luan J, Ding Y. MiR-144-3p targets FosB protooncogene, AP-1 transcription factor subunit (FOSB) to suppress proliferation, migration, and invasion of PANC-1 pancreatic cancer cells. Oncol Res. 2017;26(5):683\u201390.","journal-title":"Oncol Res"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"E765","DOI":"10.3390\/ijms18040765","volume":"18","author":"Y Wang","year":"2017","unstructured":"Wang Y, Sun T, Sun H, Yang S, Li D, Zhou D. SCF\/C-Kit\/JNK\/AP-1 signaling pathway promotes claudin-3 expression in colonic epithelium and colorectal carcinoma. Int J Mol Sci. 2017;18:E765.","journal-title":"Int J Mol Sci"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"18636","DOI":"10.1074\/jbc.M115.636548","volume":"290","author":"D Subramanian","year":"2015","unstructured":"Subramanian D, Bunjobpol W, Sabapathy K. Interplay between TAp73 protein and selected activator protein-1 (AP-1) family members promotes AP-1 target gene activation and cellular growth. J Biol Chem. 2015;290:18636\u201349.","journal-title":"J Biol Chem"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00262-011-1078-3","volume":"61","author":"J Ming","year":"2012","unstructured":"Ming J, Jiang G, Zhang Q, Qiu X, Wang E. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother. 2012;61:79\u201388.","journal-title":"Cancer Immunol Immunother"},{"key":"1568_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121568","volume":"10","author":"PG Daft","year":"2015","unstructured":"Daft PG, Yang Y, Napierala D, Zayzafoon M. The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanism. PLoS One. 2015;10:e0121568.","journal-title":"PLoS One"},{"key":"1568_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3904\/kjim.2001.16.2.93","volume":"16","author":"YH Kim","year":"2001","unstructured":"Kim YH, Oh JH, Kim NH, Choi KM, Kim SJ, Baik SH, Choi DS, Lee ES. Fra-1 expression in malignant and benign thyroid tumor. Korean J Intern Med. 2001;16:93\u20137.","journal-title":"Korean J Intern Med"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1007\/s13277-015-4476-x","volume":"37","author":"X Chen","year":"2016","unstructured":"Chen X, Wu W, Chen X, Gong X. Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma. Tumor Biol. 2016;37:6519\u201326.","journal-title":"Tumor Biol"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1210\/jc.2005-0285","volume":"90","author":"L Sophie","year":"2005","unstructured":"Sophie L, Carole R, Eric B, Bernard C, Hartl DM, Jean-Michel B, Jean-Paul T, Martin S. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00268-012-1423-5","volume":"36","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg. 2012;36:1274\u20138.","journal-title":"World J Surg"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/cen.13032","volume":"85","author":"TP Castro De","year":"2016","unstructured":"De Castro TP, Waissmann W, Simoes TC, De Mello RCR, Carvalho DP. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study. Clin Endocrinol. 2016;85:466\u201374.","journal-title":"Clin Endocrinol"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418\u201328.","journal-title":"Am J Med"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/nar\/gkr1216","volume":"40","author":"W Dong","year":"2012","unstructured":"Dong W, Li Y, Gao M, Hu M, Li X, Mai S, Guo N, Yuan S, Song L. IKK\u03b1 contributes to UVB-induced VEGF expression by regulating AP-1 transactivation. Nucleic Acids Res. 2012;40:2940\u201355.","journal-title":"Nucleic Acids Res"},{"key":"1568_CR25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbrc.2018.02.147","volume":"497","author":"H Motomura","year":"2018","unstructured":"Motomura H, Seki S, Shiozawa S, Aikawa Y, Nogami M, Kimura T. A selective c-Fos\/AP-1 inhibitor prevents cartilage destruction and subsequent osteophyte formation. Biochem Biophys Res Commun. 2018;497:756\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"1568_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3892\/ijo.2017.4100","volume":"51","author":"D Luo","year":"2017","unstructured":"Luo D, Chen H, Li X, Lu P, Long M, Peng X, Lin S, Tan L, Zhu Y, Ouyang N, Li H. Activation of the ROCK1\/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma. Int J Oncol. 2017;51:1209\u201318.","journal-title":"Int J Oncol"},{"key":"1568_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biochi.2007.01.015","volume":"89","author":"B Rothhut","year":"2007","unstructured":"Rothhut B, Ghoneim C, Antonicelli F, Soularothhut M. Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through focal adhesion kinase. Biochimie. 2007;89:613\u201324.","journal-title":"Biochimie"},{"key":"1568_CR28","doi-asserted-by":"crossref","first-page":"73242","DOI":"10.18632\/oncotarget.12303","volume":"7","author":"WS Shin","year":"2016","unstructured":"Shin WS, Hong Y, Lee HW, Lee ST. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-\u03baB in esophageal squamous cell carcinoma cells. Oncotarget. 2016;7:73242\u201356.","journal-title":"Oncotarget"},{"key":"1568_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/0300060513505485","volume":"42","author":"XY Meng","year":"2014","unstructured":"Meng XY, Zhang Q, Li Q, Lin S, Li J. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations. J Int Med Res. 2014;42:619\u201327.","journal-title":"J Int Med Res"},{"key":"1568_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/10799893.2015.1122045","volume":"36","author":"YS Li","year":"2016","unstructured":"Li YS, Deng ZH, Zeng C, Lei GH. JNK pathway in osteosarcoma: pathogenesis and therapeutics. J Recept Signal Transduct Res. 2016;36:465\u201370.","journal-title":"J Recept Signal Transduct Res"},{"key":"1568_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00006676-200301000-00011","volume":"26","author":"T Meggiato","year":"2003","unstructured":"Meggiato T, Calabrese F, De Cesare CM, Baliello E, Valente M, Del FG. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death. Pancreas. 2003;26:65.","journal-title":"Pancreas"},{"key":"1568_CR32","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","volume":"20","author":"E Shaulian","year":"2001","unstructured":"Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20:2390\u2013400.","journal-title":"Oncogene"},{"key":"1568_CR33","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1210\/jc.2005-2472","volume":"91","author":"CS Mitsiades","year":"2006","unstructured":"Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab. 2006;91:4013\u201321.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-019-1568-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T23:00:55Z","timestamp":1606345255000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-019-1568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1186\/s12957-019-1568-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"11 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of Shengjing Hospital of China Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}